Mass Spectrometry Market Report and Forecast 2025-2034

The global mass spectrometry market was valued at USD 5.40 Billion in 2024 driven by the increasing demand for biopharmaceuticals and the technological advancements across the globe. It is expected to grow at a CAGR of 7.50% during the forecast period of 2025-2034 and attain a market value of USD 11.13 Billion by 2034.

Mass Spectrometry Market Overview

Mass spectrometry is an advanced analytical method that enables the identification and quantification of various compounds by analyzing their mass-to-charge ratios. The increasing interest in biopharmaceuticals and personalized medicine is propelling the market's growth, as sophisticated instruments are essential for maintaining quality standards and regulatory compliance. Notable trends include ongoing technological advancements, new regulatory approvals, and strategic partnerships, all of which are transforming the market. These developments are not only driving expansion but also positioning mass spectrometry as a crucial component in areas such as diagnostics, pharmaceuticals, and environmental monitoring.

Mass Spectrometry Market Growth Drivers

Increasing Demand for Biopharmaceuticals Driving Market Growth

The rising demand for biopharmaceuticals is significantly driving the growth of the market. As biopharmaceuticals, including gene therapies, vaccines, and antibodies, often contain complex biological materials, there is an increasing need for sophisticated analytical techniques to ensure product quality and safety. As per analysis by Expert Market Research, the global biopharmaceutical market is expected to grow at a CAGR of 7.6% in the forecast period of 2025-2034. This heightened focus on product safety and regulatory compliance is propelling further advancements and investment in mass spectrometry technologies.

Mass Spectrometry Market Trends

Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:

Rise in Collaborations to Affect the Market Landscape Significantly

The rise in collaboration among the market leaders is significantly transforming the market landscape, particularly in laboratory automation. For instance, in February 2023, SCIEX announced a collaboration with HighRes Biosolutions to enhance laboratory automation. Their combined solutions integrate HighRes's Cellario™ software with SCIEX's Echo® MS system, aimed at providing customizable workflows for high-throughput screening and synthetic biology studies. This partnership focused on customizable workflows for high-throughput screening and synthetic biology, aiming to optimize data capture, ultimately reshaping the impact of automation on bioanalytical workflow.

Technological Advancements to Enhance Mass Spectrometry Market Growth

Recent innovations in mass spectrometry have played a crucial role in driving the market landscape. For instance, in January 2024, Shimadzu Scientific Instruments launched the ICPMS-2040/2050 series, featuring a mini-torch system and a redesigned collision/reaction cell. These inductively coupled plasma mass spectrometers provide high-performance quadrupole mass filters with enhanced resolution, demonstrating the continued evolution and competitiveness of this segment in the market.

Launch of Advanced LC/MS Systems Boosting Mass Spectrometry Market Value

The launch of advanced liquid mass spectrometry systems is shaping the market value. For instance, in June 2023, Agilent Technologies introduced the Agilent 6495D LC/TQ and Agilent Revident LC/Q-TOF systems. This was complemented by the release of Agilent MassHunter Explorer Profiling software and the Agilent ChemVista library manager software, enhancing the performance capabilities of the Revident LC/Q-TOF and underscoring the company’s commitment to innovation in analytical technology.

Surge in Regulatory Approvals to Boost Mass Spectrometry Market SIze

The rising regulatory approvals are catalyzing growth in the market. For instance, in December 2024, Roche announced the CE mark approval for its cobas® Mass Spec solution, which includes the cobas® I 601 analyzer and the first Ionify® reagent pack for steroid hormone assays. This groundbreaking solution aimed to bring automated, integrated, and standardized clinical mass spectrometry testing to routine laboratories worldwide, with plans to offer over 60 analytes for various tests, including steroid hormones, vitamin D metabolites, and therapeutic drug monitoring.

Mass Spectrometry Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

• Instruments
• Hybrid Mass Spectrometry
• Triple Quadrupole
• Quadrupole ToF (Q-ToF)
• Single Mass Spectrometry
• Quadrupole
• Time-Of-Flight (ToF)
• Ion Trap
• Software and Services

Market Breakup by Techniques

• GC-MS
• LC-MS
• ICP-MS
• Others

Market Breakup by Application

• OMICS Research (Genomics, Proteomics and Metabolomics)
• Drug Discovery
• Environmental Testing
• Food Testing
• Pharma-Biopharma Manufacturing
• Clinical Diagnostics
• Applied Industries
• Others

Market Breakup by End User

• Pharmaceutical Companies
• Biotechnology Companies
• Research Labs and Academic Institutes
• Forensic Labs
• Food and Beverage Industry
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Mass Spectrometry Market Share

Based on the End User Pharmaceutical Companies Hold a Substantial Market Growth

Based on end-user, the market is divided into pharmaceutical companies, biotechnology companies, research labs and academic institutes, forensic labs, as well as the food and beverage industry, among others. Among these, the pharmaceutical companies are expected to domain to dominate the market due to their focus on developing personalized medicine, aimed at addressing the unique needs of patients. Mass spectrometers are crucial as they provide vital measurements of metabolites, specific biomarkers, and drug compounds in biological samples from patients, thereby supporting the advancements of personalized therapeutic approaches.

Mass Spectrometry Market Analysis by Region

Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. Among these, North America is expected to dominate the market in the forecast period. The well-established pharmaceutical industry has fueled a significant rise in demand for mass spectrometry. Pharmaceutical companies are involved in developing reliable and efficient instruments to ensure accurate data analysis in drug discovery, and detection. Additionally, biochemical analysis, forensic science, and environmental testing are poised to further accelerate growth in this region.

Leading Players in the Mass Spectrometry Market

The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:

SCIEX AB

SCIEX was founded in 1974 and headquartered in Framingham, USA. The company has been a pioneer in mass spectrometry, introducing the first commercially successful triple quadrupole mass spectrometer in 1981. SCIEX launched the 7500+ system, enhancing its quantitative mass spectrometry portfolio with high sensitivity and resilience.

Thermo Fisher Scientific

Thermo Fisher Scientific was established in 1956 through the merger of Thermo Electron and Fisher Scientific, with its headquarters in Waltham, USA. The company offers a comprehensive range of mass spectrometry products, including the Orbitrap series and triple quadrupole mass spectrometers. The company also introduced the Orbitrap Astral mass spectrometer, combining rapid throughput with high sensitivity to advance scientific discoveries.

Agilent Technologies, Inc

Agilent Technologies was founded in 1999 and is based in California, USA. Agilent provides a comprehensive portfolio of LC-MS, GC-MS, and ICP-MS instruments in the mass spectrometry market. Agilent developed the triple quadrupole GC/MS System, designed for enhanced sensitivity and robustness in food and environmental markets.

Waters Corporation

Waters Corporation was established in 1958 and is headquartered in Massachusetts, USA. The company offers a range of mass spectrometry products, including the ACQUITY UPLC systems and Xevo mass spectrometry systems. Waters introduced the Xevo MRT Mass Spectrometer, utilizing advanced multi-reflecting time-of-flight technology to provide superior resolution and speed for large-scale biomedical research.

Other companies include PerkinElmer Inc., Shimadzu Corporation, Bruker Corporation, Analytik Jena GmbH, JEOL Ltd, MKS Instruments, Inc., and Hiden Analytical Ltd

Key Questions Answered in the Global Mass Spectrometry Market

• What was the global mass spectrometry market value in 2024?
• What is the global mass spectrometry market forecast outlook for 2025-2034?
• What are the regional markets covered in the report?
• What is the market segmentation based on the product?
• What is the market breakup based on the technique?
• What is the market segmentation based on the application?
• What is the market breakup based on the end user?
• What are the major factors aiding the global mass spectrometry market demand?
• What are the market's major drivers, opportunities, and restraints?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• What are the major global mass spectrometry market trends?
• How does the rise in the geriatric population impact the market size?
• Who are the key players involved in the global mass spectrometry market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.